Deregulated NLRP3 and NLRP1 inflammasomes and their correlations with disease activity in systemic lupus erythematosus

Q Yang, C Yu, Z Yang, Q Wei, K Mu, Y Zhang… - The Journal of …, 2014 - jrheum.org
Q Yang, C Yu, Z Yang, Q Wei, K Mu, Y Zhang, W Zhao, X Wang, W Huai, L Han
The Journal of Rheumatology, 2014jrheum.org
Objective. NOD-like receptor family, pyrin domain containing 3 and 1 (NLRP3 and NLRP1)
inflammasomes are molecular platforms that sense the damage or danger signals of cells.
We investigated whether NLRP3/NLRP1 inflammasomes are involved in the pathogenesis
and progression of systemic lupus erythematosus (SLE). Methods. Expressions of
inflammasome components at the mRNA and protein levels in the peripheral blood
mononuclear cells (PBMC) from patients with SLE and healthy controls were investigated by …
Objective
NOD-like receptor family, pyrin domain containing 3 and 1 (NLRP3 and NLRP1) inflammasomes are molecular platforms that sense the damage or danger signals of cells. We investigated whether NLRP3/NLRP1 inflammasomes are involved in the pathogenesis and progression of systemic lupus erythematosus (SLE).
Methods
Expressions of inflammasome components at the mRNA and protein levels in the peripheral blood mononuclear cells (PBMC) from patients with SLE and healthy controls were investigated by quantitative real-time transcription PCR and Western blot, respectively. Correlations between NLRP3/NLRP1 inflammasome components’ expression and clinical disease progression were investigated. Expressions of NLRP3/NLRP1 inflammasomes before and after treatment in the patients with SLE were also analyzed and compared.
Results
Our data showed that expressions of NLRP3/NLRP1 inflammasomes were significantly downregulated in PBMC from patients with SLE compared with PBMC from healthy controls. Further, expressions of NLRP3/NLRP1 inflammasomes were negatively correlated with the SLE Disease Activity Index, and regular glucocorticoid treatment significantly corrected this deregulation of these inflammasomes. Further analysis showed that type I interferon (IFN) level was significantly negatively correlated with expression of NLRP3/NLRP1 inflammasomes, which indicated that enhanced IFN-I level in patients with SLE was responsible, at least to a great degree, for the deregulation of inflammasomes.
Conclusion
These results indicated deregulation of NLRP3/NLRP1 inflammasomes in patients with SLE, and suggested an important role for inflammasomes in the pathogenesis and progression of SLE.
jrheum.org